S-100B and Neuron-specific Enolase (NSE) in Spinal Trauma

计划入组 60 人 · 首次发布于 2009 年 9 月 21 日

Neuron Specific Enolase (NSE) as Outcome Parameter of Cooling Therapy After Survived Sudden Cardiac Death

计划入组 108 人 · 首次发布于 2010 年 4 月 13 日

The Use of Cooling Helmet for Neuroprotection Management in Open Heart Surgery

计划入组 26 人 · 首次发布于 2022 年 3 月 3 日

Neuron-specific membrane KCC2 gene therapy (AXONIS Therapeutics)

NTF-108 (Neuron Therapeutics)

overactive neuron-mediating drug candidate

Naturally Splendid Enterprises Ltd

United States

Telix Pharmaceuticals

Australia

Repare Therapeutics

United States

FDA Grants Breakthrough Device Designation to TETmedical's NSE-FAST, the First Rapid Blood Test for Acute Ischemic Stroke Diagnosis

Surufatinib and Toripalimab Combination Shows Promise in Extensive-Stage Small Cell Lung Cancer

Soccer Heading Linked to Acute Spikes in Neural Damage Biomarkers S100B and p-tau217 in Amateur Players